Suvizumab (KD-247) is a neutralizing monoclonal antibody targeting HIV-1. Demonstrating potent efficacy, Suvizumab effectively neutralizes diverse HIV-1 strains including HIV-1MN, HIV-1SF2, and HIV-189.6, with respective IC50 values of 0.1 ??g/mL, 1.0 ??g/mL, and 0.2 ??g/mL. This antibody has been shown to significantly reduce viral load, offering a promising therapeutic option for the management of HIV infection. Suvizumab is well-tolerated and holds potential for both therapeutic and prophylactic applications in HIV management.
Suvizumab (KD-247) is a neutralizing monoclonal antibody targeting HIV-1. Demonstrating potent efficacy, Suvizumab effectively neutralizes diverse HIV-1 strains including HIV-1MN, HIV-1SF2, and HIV-189.6, with respective IC50 values of 0.1 ??g/mL, 1.0 ??g/mL, and 0.2 ??g/mL. This antibody has been shown to significantly reduce viral load, offering a promising therapeutic option for the management of HIV infection. Suvizumab is well-tolerated and holds potential for both therapeutic and prophylactic applications in HIV management.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
